These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 23818363)
1. Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma. Guo T; Li B; Gu C J BUON; 2013; 18(2):465-70. PubMed ID: 23818363 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591 [TBL] [Abstract][Full Text] [Related]
3. [Correlation between receptor status and results of treatment in endometrial carcinoma]. Baĭnazarova AA; Iskakova ZhK Vopr Onkol; 2006; 52(6):654-8. PubMed ID: 17338243 [TBL] [Abstract][Full Text] [Related]
4. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index. Kapucuoglu N; Aktepe F; Kaya H; Bircan S; Karahan N; Ciriş M Pathol Res Pract; 2007; 203(3):153-62. PubMed ID: 17317031 [TBL] [Abstract][Full Text] [Related]
7. [Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma]. Chen YP; Shen M; Chen C Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):123-5. PubMed ID: 12536641 [TBL] [Abstract][Full Text] [Related]
8. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors. Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812 [TBL] [Abstract][Full Text] [Related]
9. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas. Olech-Fudali E; Chibowski D; Skomra D; Walczyna B Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333 [TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer. Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875 [TBL] [Abstract][Full Text] [Related]
11. Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus. Bonneterre J; Hutt E; Bosq J; Graham JD; Powell MA; Leblanc E; Fujiwara K; Herzog TJ; Coleman RL; Clarke CL; Gilles EM; Zukiwski AA; Monk BJ Gynecol Oncol; 2015 Sep; 138(3):663-7. PubMed ID: 26142884 [TBL] [Abstract][Full Text] [Related]
12. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. Voss MA; Ganesan R; Ludeman L; McCarthy K; Gornall R; Schaller G; Wei W; Sundar S Gynecol Oncol; 2012 Jan; 124(1):15-20. PubMed ID: 21864888 [TBL] [Abstract][Full Text] [Related]
13. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas. Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803 [TBL] [Abstract][Full Text] [Related]
14. [Estrogen and progesterone receptors as prognostic markers in endometrial carcinoma]. Gorchev G; Milkov V Akush Ginekol (Sofiia); 1992; 31(2):32-3. PubMed ID: 1342555 [TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma. Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983 [TBL] [Abstract][Full Text] [Related]
16. [Estrogen and progesterone receptors in endometrial carcinoma]. Guo Y; Dang Q Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma. Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767 [TBL] [Abstract][Full Text] [Related]
18. Panel of Villin, Pro-Ex-C, Estrogen Receptor and Progesterone Receptor Expressions Could Help in Differentiation Between Endocervical and Endometrioid Adenocarcinoma. Elfeky M; Harb O; Gertallah L Turk Patoloji Derg; 2017; 1(1):29-40. PubMed ID: 28832070 [TBL] [Abstract][Full Text] [Related]
19. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer. Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443 [TBL] [Abstract][Full Text] [Related]
20. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions]. Ma XX; Zhang SL; Gao S; Lu JM; Dong F Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]